Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jr Fraser Cummings

17PUBLICATIONS
80CO-AUTHORS
Epidemiological methodsImmunogenetics (incl. genetic immunology)Rheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Information systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

Sort by Publication Date:
|Jul 10, 2026
Real-World Effectiveness, Safety and Quality of Life With Ustekinumab for the Treatment of Crohn's Disease: Results of the UK Ustekinumab Real World Evidence Study (UndieS) Study Group.

|Jun 04, 2026
The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes.

|Jan 23, 2026
Comparative analysis of inflammatory bowel disease (IBD) patient- and service-reported quality of care using 2019 and 2023 UK benchmarking data from more than 26 000 adult patient respondents and 154 IBD services.

A Barney Hawthorne, Paul Christiansen, Ian Arnott

|Jan 23, 2026
Research engagement and patient-reported quality of care: a cross-sectional study of UK inflammatory bowel disease services.

Robert J Mulligan, Pat Ryan, Lauren C Beck

|May 11, 2024
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS).

David Young, Clare Harris, Sohail Rahmany

|Nov 13, 2023
Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe.

Ran Jin, Chidozie Nduka, Delphine Courmier

Pageof 3

Frequent Collaborators

5 joint publications

Christopher Andrew Lamb

3 joint publications

Tariq Ahmad

3 joint publications

Nicholas A Kennedy

3 joint publications

Keith Bodger

3 joint publications

David Young

2 joint publications

Shaji Sebastian

2 joint publications

A Barney Hawthorne

2 joint publications

Simeng Lin

2 joint publications

Neil Chanchlani

2 joint publications

Robert J Mulligan

Frequent Collaborators

5 joint publications

Christopher Andrew Lamb

3 joint publications

Tariq Ahmad

3 joint publications

Nicholas A Kennedy

3 joint publications

Keith Bodger